Appian and PSI CRO join forces to automate clinical trial processes using AI-driven orchestration, aiming to enhance operational efficiency across the entire research lifecycle.
Appian has entered a strategic partnership with PSI CRO to implement its AI-powered process orchestration platform within the life sciences sector. This collaboration focuses on streamlining clinical trial workflows, marking a significant expansion of Appian's footprint in the highly regulated pharmaceutical research industry.
The partnership aims to develop an AI-powered platform to orchestrate processes across the entire lifecycle of clinical trials.
No, the companies have stated that this initial project serves as the foundation for a broader, long-term platform strategy.
PSI CRO entered a strategic partnership with Appian to leverage AI-driven process orchestration across clinical trial lifecycles, enhancing its operational capabilities.
Appian and PSI CRO have launched a strategic partnership to integrate AI-powered process orchestration into clinical trial lifecycles. The collaboration aims to streamline complex research workflows, marking a significant expansion for Appian's software platform within the global life sciences sector.
The partnership aims to orchestrate clinical trial processes using AI to improve efficiency and management across the entire research lifecycle.
The collaboration expands Appian's presence in the life sciences sector by demonstrating the utility of its platform in highly regulated and complex clinical environments.